Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Clinical trial NCT03547206 · TERMINATED
Trial details
- NCT number
- NCT03547206
- Sponsor
- Regenera Pharma Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2020-09-27
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.